Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferase

被引：56

作者：

Rackham, Mark D. ^{[1
]}

Brannigan, James A. ^{[2
]}

Moss, David K. ^{[3
]}

Yu, Zhiyong ^{[1
]}

Wilkinson, Anthony J. ^{[2
]}

Holder, Anthony A. ^{[3
]}

Tate, Edward W. ^{[1
]}

Leatherbarrow, Robin J. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England

[2] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England

[3] MRC Natl Inst Med Res, Div Parasitol, London NW7 1AA, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2013年 / 56卷 / 01期

基金：

英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国工程与自然科学研究理事会;

关键词：

DESIGN;

D O I：

10.1021/jm301474t

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

N-Myristoyltransferase (NMT) is an attractive antiprotozoan drug target. A lead-hopping approach was utilized in the design and synthesis of novel benzo[b]thiophene-containing inhibitors of Plasmodium falciparum (PO and Plasmodium vivax (Pv) NMT. These inhibitors are selective against Homo sapiens NMT1 (HsNMT), have excellent ligand efficiency (LE), and display antiparasitic activity in vitro. The binding mode of this series was determined by crystallography and shows a novel binding mode for the benzothiophene ring.

引用

页码：371 / 375

页数：5

共 17 条

[1] [Anonymous], 2012, TDR BIENN REP 2010 1
[2] Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs
Bell, Andrew S.
Mills, James E.
Williams, Gareth P.
Brannigan, James A.
Wilkinson, Anthony J.
Parkinson, Tanya
Leatherbarrow, Robin J.
Tate, Edward W.
Holder, Anthony A.
Smith, Deborah F.
[J]. PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (04):
[3] N-myristoyltransferase:: a prospective drug target for protozoan parasites
Bowyer, Paul W.
Tate, Edward W.
Leatherbarrow, Robin J.
Holder, Anthony A.
Smith, Deborah F.
Brown, Katherine A.
[J]. CHEMMEDCHEM, 2008, 3 (03) : 402 - 408
[4] Cyclization of 4-hydroxy-3-hydroxyalkylcarbostyrils under mitsunobu conditions
Coppola, GM
[J]. SYNTHETIC COMMUNICATIONS, 2004, 34 (18) : 3381 - 3387
[5] Artemisinin Resistance in Plasmodium falciparum Malaria.
Dondorp, Arjen M.
Nosten, Francois
Yi, Poravuth
Das, Debashish
Phyo, Aung Phae
Tarning, Joel
Lwin, Khin Maung
Ariey, Frederic
Hanpithakpong, Warunee
Lee, Sue J.
Ringwald, Pascal
Silamut, Kamolrat
Imwong, Mallika
Chotivanich, Kesinee
Lim, Pharath
Herdman, Trent
An, Sen Sam
Yeung, Shunmay
Singhasivanon, Pratap
Day, Nicholas P. J.
Lindegardh, Niklas
Socheat, Duong
White, Nicholas J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (05) : 455 - 467
[6] Tautomerism of heterocycles: Five-membered rings with one heteroatom
Friedrichsen, W
Traulsen, T
Elguero, J
Katritzky, AR
[J]. ADVANCES IN HETEROCYCLIC CHEMISTRY, VOL 76, 2000, 76 : 85 - 156
[7] Discovery of Plasmodium vivax N-Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode
Goncalves, Victor
Brannigan, James A.
Whalley, David
Ansell, Keith H.
Saxty, Barbara
Holder, Anthony A.
Wilkinson, Anthony J.
Tate, Edward W.
Leatherbarrow, Robin J.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3578 - 3582
[8] GENETIC AND BIOCHEMICAL-STUDIES OF PROTEIN N-MYRISTOYLATION
JOHNSON, DR
BHATNAGAR, RS
KNOLL, LJ
GORDON, JI
[J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 : 869 - 914
[9] KATRITZKY AR, 1991, HETEROCYCLES, V32, P127
[10] Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase.: Part 3
Kawasaki, K
Masubuchi, M
Morikami, K
Sogabe, S
Aoyama, T
Ebiike, H
Niizuma, S
Hayase, M
Fujii, T
Sakata, K
Shindoh, H
Shiratori, Y
Aoki, Y
Ohtsuka, T
Shimma, N
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (01) : 87 - 91

← 1 2 →